Cargando…
Evidence for using dextromethorphan-quinidine for the treatment of agitation in dementia
Behavioral and psychological symptoms including agitation are common in dementia, and are associated with decreased quality of life, increased risk of institutionalization, and greater patient and caregiver distress. Pharmacological agents used for management of behavioral and psychological symptoms...
Autores principales: | Tampi, Rajesh R, Joshi, Pallavi, Marpuri, Padmapriya, Tampi, Deena J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203083/ https://www.ncbi.nlm.nih.gov/pubmed/32399396 http://dx.doi.org/10.5498/wjp.v10.i4.29 |
Ejemplares similares
-
Deuterated dextromethorphan/quinidine for agitation in Alzheimer's disease
por: Khoury, Rita
Publicado: (2021) -
Analgesics in the management of behavioral and psychological symptoms of dementia: a perspective review
por: Tampi, Rajesh R, et al.
Publicado: (2017) -
Propranolol for the management of behavioural and psychological symptoms of dementia
por: Tampi, Rajesh R, et al.
Publicado: (2022) -
Evidence for using pimavanserin for the treatment of Parkinson's disease psychosis
por: Tampi, Rajesh R, et al.
Publicado: (2019) -
Evaluating the safety and efficacy of dextromethorphan/quinidine in the treatment of pseudobulbar affect
por: Schoedel, Kerri A, et al.
Publicado: (2014)